|
gptkb:finasteride
|
may cause birth defects in male fetus
|
|
gptkb:ibrutinib
|
may cause fetal harm
|
|
gptkb:azacitidine
|
may cause fetal harm
|
|
gptkb:CellCept
|
may cause birth defects
|
|
gptkb:cariprazine
|
may cause extrapyramidal and/or withdrawal symptoms in neonates
|
|
gptkb:Nintedanib
|
may cause fetal harm
|
|
gptkb:Altace
|
can cause injury and death to the developing fetus
|
|
gptkb:griseofulvin
|
may cause fetal harm
|
|
gptkb:Fingolimod
|
may cause fetal harm
|
|
gptkb:Imbruvica
|
may cause fetal harm
|
|
gptkb:Tafluprost
|
use only if potential benefit justifies potential risk
|
|
gptkb:Pemigatinib
|
may cause fetal harm
|
|
gptkb:Lexapro
|
use only if clearly needed
|
|
gptkb:Entresto
|
may cause fetal harm
|
|
gptkb:dolutegravir
|
possible risk of neural tube defects
|
|
gptkb:Afatinib
|
may cause fetal harm
|
|
gptkb:Gilenya
|
may cause fetal harm
|
|
gptkb:fingolimod
|
teratogenic
|
|
gptkb:Topamax
|
may cause birth defects
|
|
gptkb:Hydroxyzine
|
may cause fetal harm
|